PharmEasy sees valuation jump to $1.8 Bn with B Capital’s $20 Mn Ttansaction: Report


Content Team
Image Credit: shortpedia

Ahead of a potential IPO within the next year, PharmEasy’s valuation has shot up $1.8 Bn after a secondary transaction from Facebook cofounder Eduardo Saverin’s B Capital. B Capital is said to have picked up a minority stake in the online pharmacy and teleconsultation platform with the $20 Mn secondary deal. While the secondary deal will not bring in new capital for PharmEasy.